Ignite Creation Date:
2024-05-06 @ 10:20 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03226678
Status:
COMPLETED
Last Update Posted:
2023-04-03
First Post:
2017-07-07
Brief Title:
Study to Assess the Safety Tolerability Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia wAIHA or Cold Agglutinin Disease CAD
Sponsor:
Organization:
Apellis Pharmaceuticals Inc
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
24
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: